Location History:
- Daejon, KR (2014)
- Daejeon, KR (2015 - 2017)
Company Filing History:
7 out of 321 
2 out of 10 Years Active: 2014-2017
Title: Innovator Spotlight: Semi Kim - Pioneering Cancer Treatments
Introduction:
Meet Semi Kim, a prolific inventor hailing from Daejeon, South Korea, who has made significant contributions to the field of cancer research and treatment. With an impressive portfolio of 9 patents, his work revolves around developing pharmaceutical compositions for cancer prevention and treatment.
Latest Patents:
Kim's latest patents showcase his innovative approach towards combating cancer. One notable invention is the "Pharmaceutical composition for cancer prevention and treatment containing peptide originated from C12orf59 protein as an active ingredient." This composition targets cancer cell invasion and survivability, offering potential as a clinical marker for screening cancer treatment agents and predicting pathological stages.
Another groundbreaking patent is the "Method for screening anticancer agent or SIP1/ZEB2 inhibitor using integrin alpha 5." This method enables the screening of anticancer agents by measuring integrin alpha 5 expression patterns, thereby simplifying the process of identifying potential treatments for cancer.
Career Highlights:
Throughout his career, Kim has held key positions at prestigious institutions such as the Korea Research Institute of Bioscience and Biotechnology and Pharmabcine Inc. His dedication to cancer research has led to the development of novel treatment methods that have the potential to revolutionize cancer therapy.
Collaborations:
Kim has collaborated with esteemed colleagues in his field, including Jin-San Yoo and Yunhee Lee. Together, they have worked towards advancing cancer research and developing innovative solutions for the prevention and treatment of this devastating disease.
Conclusion:
In conclusion, Semi Kim stands out as a visionary inventor in the realm of cancer research, with his pioneering work shaping the future of oncology. His dedication to developing novel pharmaceutical compositions and screening methods underscores his commitment to improving cancer treatment outcomes. We look forward to seeing more groundbreaking innovations from Semi Kim in the future.